All Stories

  1. Disease-modifying anti-nephropathic drugs (DMANDs)—a definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)

    Article • Nephrology Dialysis Transplantation, February 2025, Oxford University Press (OUP)

    Eleni Frangou

  2. Sex dimorphism in kidney health and disease: mechanistic insights and clinical implication

    Article • Kidney International, January 2025, Elsevier

    Eleni Frangou

  3. Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al

    Article • Annals of the Rheumatic Diseases, October 2024, Elsevier

    Eleni Frangou

  4. Antibody-mediated podocytopathies: a disease entity that implies immunotherapy

    Article • Nephrology Dialysis Transplantation, July 2024, Oxford University Press (OUP)

    Eleni Frangou

  5. Immunoengineering for autoimmune-kidney disease

    Article • Nephrology Dialysis Transplantation, June 2024, Oxford University Press (OUP)

    Eleni Frangou

  6. Immunosuppression Withdrawal in Patients with Lupus Nephritis

    Article • Journal of the American Society of Nephrology, April 2024, Wolters Kluwer Health

    Eleni Frangou

  7. AA Amyloidosis: A Contemporary View

    Article • Current Rheumatology Reports, April 2024, Springer Science + Business Media

    Eleni Frangou

  8. Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group

    Article • Nephrology Dialysis Transplantation, February 2024, Oxford University Press (OUP)

    Eleni Frangou

  9. EULAR 2023 recommendations for SLE treatment: synopsis for the management of lupus nephritis: the European Renal Association–Immunonephrology Working Group (ERA-IWG) perspective

    Article • Nephrology Dialysis Transplantation, October 2023, Oxford University Press (OUP)

    Eleni Frangou

  10. Sodium bicarbonate in kidney transplant recipients: do some apples a day keep the doctor away?

    Article • Clinical Kidney Journal, June 2023, Oxford University Press (OUP)

    Eleni Frangou

  11. Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction

    Article • Autoimmunity Reviews, June 2023, Elsevier

    Eleni Frangou

  12. Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations

    Article • Nephrology Dialysis Transplantation, May 2023, Oxford University Press (OUP)

    Eleni Frangou

  13. Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy

    Article • BMC Genomics, April 2023, Springer Science + Business Media

    Eleni Frangou

  14. Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG)

    Article • Nephrology Dialysis Transplantation, March 2023, Oxford University Press (OUP)

    Eleni Frangou

  15. Patient-derived podocyte spheroids reveal new insights into the etiopathogenesis of Alport syndrome

    Article • Frontiers in Cell and Developmental Biology, March 2023, Frontiers

    Eleni Frangou

  16. Novel and Founder Pathogenic Variants in X-Linked Alport Syndrome Families in Greece

    Article • Genes, November 2022, MDPI AG

    Eleni Frangou

  17. Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis

    Article • Annals of the Rheumatic Diseases, October 2022, Elsevier

    Eleni Frangou

  18. Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs

    Article • Frontiers in Immunology, May 2022, Frontiers

    Eleni Frangou

  19. Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS

    Article • Nephrology Dialysis Transplantation, March 2022, Oxford University Press (OUP)

    Eleni Frangou, Dr Stephen P McAdoo

  20. The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021

    Article • Nephrology Dialysis Transplantation, December 2021, Oxford University Press (OUP)

    Eleni Frangou

  21. The management of membranous nephropathy—an update

    Article • Nephrology Dialysis Transplantation, November 2021, Oxford University Press (OUP)

    Eleni Frangou

  22. POS0421 COMBINED ANALYSIS OF METABOLIC AND TRANSCRIPTOMIC KIDNEY PROFILES OF NZW/B-F1 MURINE LUPUS UNCOVERS BIOLOGICAL MECHANISMS PRECEDING THE ONSET OF NEPHRITIS

    Article • Annals of the Rheumatic Diseases, June 2021, Elsevier

    Eleni Frangou

  23. Gene Expression as a Guide to the Development of Novel Therapies in Primary Glomerular Diseases

    Article • Journal of Clinical Medicine, May 2021, MDPI AG

    Eleni Frangou

  24. Treatment and long-term outcome in primary nephrogenic diabetes insipidus

    Article • Nephrology Dialysis Transplantation, December 2020, Oxford University Press (OUP)

    Eleni Frangou

  25. Update on the cellular and molecular aspects of lupus nephritis

    Article • Clinical Immunology, July 2020, Elsevier

    Eleni Frangou

  26. 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis

    Article • Annals of the Rheumatic Diseases, June 2020, Elsevier

    Eleni Frangou

  27. OP0163 2019 UPDATE OF THE JOINT EUROPEAN LEAGUE AGAINST RHEUMATISM AND EUROPEAN RENAL ASSOCIATION–EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE MANAGEMENT OF LUPUS NEPHRITIS

    Article • Annals of the Rheumatic Diseases, June 2020, Elsevier

    Eleni Frangou

  28. THU0014 COMPARATIVE TRANSCRIPTOME ANALYSES ACROSS TISSUES AND SPECIES IDENTIFY TARGETABLE GENES FOR HUMAN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND LUPUS NEPHRITIS (LN)

    Article • Annals of the Rheumatic Diseases, June 2020, Elsevier

    Eleni Frangou

  29. An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): Implications for the pathogenesis and treatment

    Article • Autoimmunity Reviews, August 2019, Elsevier

    Eleni Frangou

  30. Clinical course and outcome after kidney transplantation in patients with C3 glomerulonephritis due to CFHR5 nephropathy

    Article • Nephrology Dialysis Transplantation, March 2019, Oxford University Press (OUP)

    Eleni Frangou

  31. REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A)

    Article • Annals of the Rheumatic Diseases, February 2019, Elsevier

    Eleni Frangou

  32. The family of 14-3-3 proteins and specifically 14-3-3σ are up-regulated during the development of renal pathologies

    Article • Journal of Cellular and Molecular Medicine, June 2018, Wiley

    Eleni Frangou

  33. Diagnosis and management of asymptomatic bacteriuria in kidney transplant recipients: a survey of current practice in Europe

    Article • Nephrology Dialysis Transplantation, April 2018, Oxford University Press (OUP)

    Eleni Frangou

  34. Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debate

    Article • Autoimmunity Reviews, January 2018, Elsevier

    Eleni Frangou

  35. Gene expression and regulation in systemic lupus erythematosus

    Article • European Journal of Clinical Investigation, July 2013, Wiley

    Eleni Frangou

  36. Transcription of the Tumor Suppressor Genesp53andRBin Lymphocytes from Patients with Chronic Kidney Disease: Evidence of Molecular Senescence?

    Article • International Journal of Nephrology, January 2012, Wiley

    Eleni Frangou

  37. Body Mass Index and Mortality in CKD: Explaining The Obesity Paradox

    Article • American Journal of Kidney Diseases, March 2008, Elsevier

    Eleni Frangou

  38. Aliskiren as an Alternative in a Patient With Life-Threatening ACE Inhibitor–induced Angioedema

    Article • American Journal of Kidney Diseases, March 2008, Elsevier

    Eleni Frangou

  39. Serum oxidized low‐density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients

    Article • Nephrology, October 2006, Wiley

    Eleni Frangou